The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Flatiron Health
Stock and Other Ownership Interests - Flatiron Health
Sequencing of ramucirumab (ram) and immune checkpoint inhibitors (ICIs) in platinum (Pt)-treated real-world patients (pts) with advanced non-small cell lung cancer (aNSCLC).
 
Jeffrey Melson Clarke
Consulting or Advisory Role - Inivata; Premier, Inc.
Speakers' Bureau - Guardant Health; Merck
Research Funding - Abbvie; Adaptimmune; Bristol-Myers Squibb; Genentech/Roche; medpacto; Moderna Therapeutics; Spectrum Pharmaceuticals
 
Cliff Molife
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Rebecca Miksad
No Relationships to Disclose
 
Marta Batus
No Relationships to Disclose
 
Katherine B. Winfree
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Anala Gossai
Employment - Flatiron Health
Stock and Other Ownership Interests - Flatiron Health
 
Victoria Jennifer Stefaniak
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Rebekah Foster
Employment - Flatiron Health
Stock and Other Ownership Interests - Flatiron Health
 
Zhanglin Lin Cui
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Aracelis Z. Torres
No Relationships to Disclose
 
Dana Feuchtbaum
No Relationships to Disclose
 
Mahesh K Tawney
No Relationships to Disclose
 
Philip D. Bonomi
Honoraria - AstraZeneca; Biodesix; Bristol-Myers Squibb; Lilly; Merck; pfizer; Roche/Genentech; Trovagene
Consulting or Advisory Role - AstraZeneca; Biodesix; Bristol-Myers Squibb; Lilly; Merck; Merck; Pfizer; Roche/Genentech; Trovagene
Research Funding - AstraZeneca (Inst); Biodesix (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Five Prime Therapeutics (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)